A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case
Authors
Keywords
Asenapine, Betahistine, Anatomical Therapeutic Chemical Code, Single Data Source, PubChem Compound
Journal
BMC Systems Biology
Volume 9, Issue Suppl 4, Pages S2
Publisher
Springer Nature
Online
2015-06-19
DOI
10.1186/1752-0509-9-s4-s2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Computational Drug Repositioning: From Data to Therapeutics
- (2013) M R Hurle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Sibutramine in the treatment of antipsychotic-induced weight gain
- (2013) Falko Biedermann et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Increasing the clozapine: Norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy
- (2013) Nancy Légaré et al. MEDICAL HYPOTHESES
- DGIdb: mining the druggable genome
- (2013) Malachi Griffith et al. NATURE METHODS
- A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors
- (2013) N. S. Jahchan et al. Cancer Discovery
- Antipsychotic agents screened as human carbonic anhydrase I and II inhibitors
- (2013) Mahmut Erzengin et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Randomized, Double-Blind, Placebo-Controlled Trial of Fluvoxamine in Patients With Schizophrenia
- (2012) Tomihisa Niitsu et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Use of genome-wide association studies for drug repositioning
- (2012) Philippe Sanseau et al. NATURE BIOTECHNOLOGY
- Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination
- (2012) Michael Poyurovsky et al. PSYCHOPHARMACOLOGY
- Drug discovery in the age of systems biology: the rise of computational approaches for data integration
- (2011) Murat Iskar et al. CURRENT OPINION IN BIOTECHNOLOGY
- Systematic Drug Repositioning Based on Clinical Side-Effects
- (2011) Lun Yang et al. PLoS One
- Polypharmacy in schizophrenia
- (2010) Mathias Zink et al. CURRENT OPINION IN PSYCHIATRY
- Systems Pharmacology
- (2010) Aislyn D. W. Boran et al. MOUNT SINAI JOURNAL OF MEDICINE
- PROMISCUOUS: a database for network-based drug-repositioning
- (2010) J. von Eichborn et al. NUCLEIC ACIDS RESEARCH
- Entrez Gene: gene-centered information at NCBI
- (2010) D. Maglott et al. NUCLEIC ACIDS RESEARCH
- A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases–schizophrenia as a case
- (2009) Jingchun Sun et al. BIOINFORMATICS
- Network analyses in systems pharmacology
- (2009) S. I. Berger et al. BIOINFORMATICS
- SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions
- (2009) Saskia Preissner et al. NUCLEIC ACIDS RESEARCH
- PubChem: a public information system for analyzing bioactivities of small molecules
- (2009) Y. Wang et al. NUCLEIC ACIDS RESEARCH
- PDTD: a web-accessible protein database for drug target identification
- (2008) Zhenting Gao et al. BMC BIOINFORMATICS
- Genomic-scale prioritization of drug targets: the TDR Targets database
- (2008) Fernán Agüero et al. NATURE REVIEWS DRUG DISCOVERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started